Abbott Laboratories(us:ABT)

    113.57

    -0.58%

    Updated on 2024-12-23

    Open:113.86
    Close:113.57
    High:114.11
    Low:112.97
    Pre Close:114.23
    Volume:2.06M
    Amount:234.23M
    Turnover:0.12%
    Shares:1.73B
    MarketCap:196.97B
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-3011464120460.37%44050
    2024-03-312892128382904073.80%17011031222
    2023-12-312851130051306275.00%2929331277
    2023-09-302736126978644373.14%1369431271
    2023-06-302721127437896873.43%14310011184
    2023-03-312721126909210172.98%13610011193
    2022-12-312758129043487874.26%2689821152
    2022-09-302675127240738872.98%9110691087
    dateorgNametotalratiochangeShareschangeRatio
    2024-06-30Vanguard Group Inc1663538949.56%10519730.64%
    2024-06-30Blackrock Inc.1311296887.54%-1946540-1.46%
    2024-06-30State Street Corp743966224.28%-342018-0.46%
    2024-06-30Capital International Investors717998264.13%16222622.31%
    2024-06-30Capital Research Global Investors572375923.29%-26747139-31.85%
    2024-06-30Morgan Stanley356169232.05%-395059-1.10%
    2024-06-30Geode Capital Management, Llc344144341.98%6807192.02%
    2024-06-30Wellington Management Group Llp255305361.47%-2727959-9.65%
    2024-06-30Northern Trust Corp206783521.19%-345034-1.64%
    2024-06-30Norges Bank203569321.17%11342955.90%

    About

    Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
    Address:100 Abbott Park Road

    Market Movers